These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Study and treatment of gestational trophoblastic diseases at the John I. Brewer Trophoblastic Disease Center, 1962-1990. Lurain JR; Sciarra JJ Eur J Gynaecol Oncol; 1991; 12(6):425-8. PubMed ID: 1667098 [TBL] [Abstract][Full Text] [Related]
25. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Morrow CP; Kletzky OA; Disaia PJ; Townsend DE; Mishell DR; Nakamura RM Am J Obstet Gynecol; 1977 Jun; 128(4):424-30. PubMed ID: 194480 [TBL] [Abstract][Full Text] [Related]
26. [Choriogonadotrophic hormone and placental tumors]. Amiel JL; Droz JP; Ben Ayed F Ann Endocrinol (Paris); 1984; 45(4-5):231-3. PubMed ID: 6535444 [TBL] [Abstract][Full Text] [Related]
27. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta. Hoshina M; Hussa R; Pattillo R; Boime I J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191 [TBL] [Abstract][Full Text] [Related]
28. [Treatment of the choriocarcinoma]. Bagshave KD Gynecol Prat; 1967; 18(6):555-68. PubMed ID: 5630236 [No Abstract] [Full Text] [Related]
29. Hydatidiform mole: diagnosis, treatment, and follow-up. Quigley MM Mil Med; 1976 Jan; 141(1):36-8. PubMed ID: 814490 [No Abstract] [Full Text] [Related]
30. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio. Sakuragi N Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652 [No Abstract] [Full Text] [Related]
31. Presentation and management of choriocarcinoma after nonmolar pregnancy. Tidy JA; Rustin GJ; Newlands ES; Foskett M; Fuller S; Short D; Rowden P Br J Obstet Gynaecol; 1995 Sep; 102(9):715-9. PubMed ID: 7547762 [TBL] [Abstract][Full Text] [Related]
32. Detection of pregnancy specific beta1-glycoprotein in formalin-fixed tissues. Horne CH; Towler CM; Milne GD J Clin Pathol; 1977 Jan; 30(1):19-23. PubMed ID: 190273 [TBL] [Abstract][Full Text] [Related]
33. Hydatidiform mole in southern Iran: a statistical survey of 113 cases. Javey H; Sajadi H Int J Gynaecol Obstet; 1978; 15(5):390-5. PubMed ID: 28969 [TBL] [Abstract][Full Text] [Related]
34. Choriocarcinoma and invasive mole. Soutter WP S Afr Med J; 1980 Feb; 57(8):265-6. PubMed ID: 6250234 [No Abstract] [Full Text] [Related]
35. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Kurman RJ; Young RH; Norris HJ; Main CS; Lawrence WD; Scully RE Int J Gynecol Pathol; 1984; 3(1):101-21. PubMed ID: 6329973 [TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management. Goldstein DP; Berkowitz RS Major Probl Obstet Gynecol; 1982; 14():1-301. PubMed ID: 6273659 [No Abstract] [Full Text] [Related]
37. [Choriocarcinoma in the Netherlands]. ten Kate-Booij MJ; Lammes FB Ned Tijdschr Geneeskd; 1984 Jan; 128(2):56-61. PubMed ID: 6322014 [No Abstract] [Full Text] [Related]
38. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438 [TBL] [Abstract][Full Text] [Related]
39. [Chorionic diseases]. Kawashima Y Horumon To Rinsho; 1974 Jan; 22(1):130-4. PubMed ID: 4857376 [No Abstract] [Full Text] [Related]